MENU
+Compare
BMY
Stock ticker: NYSE
AS OF
Oct 8, 02:35 PM (EDT)
Price
$44.70
Change
+$0.03 (+0.07%)
Capitalization
90.9B

BMY Bristol-Myers Squibb Co Forecast, Technical & Fundamental Analysis

Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders... Show more

BMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for BMY with price predictions
Oct 07, 2025

BMY in downward trend: price may decline as a result of having broken its higher Bollinger Band on October 01, 2025

BMY broke above its upper Bollinger Band on October 01, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 39 similar instances where the stock broke above the upper band. In of the 39 cases the stock fell afterwards. This puts the odds of success at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

BMY moved below its 50-day moving average on October 02, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for BMY crossed bearishly below the 50-day moving average on September 12, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BMY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for BMY entered a downward trend on September 30, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where BMY's RSI Indicator exited the oversold zone, of 33 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 58 cases where BMY's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on October 01, 2025. You may want to consider a long position or call options on BMY as a result. In of 89 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for BMY just turned positive on October 01, 2025. Looking at past instances where BMY's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BMY advanced for three days, in of 308 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.214) is normal, around the industry mean (9.701). P/E Ratio (17.936) is within average values for comparable stocks, (24.631). Projected Growth (PEG Ratio) (1.120) is also within normal values, averaging (2.046). BMY's Dividend Yield (0.056) is considerably higher than the industry average of (0.027). P/S Ratio (1.904) is also within normal values, averaging (3.590).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. BMY’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BMY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 77, placing this stock worse than average.

View a ticker or compare two or three
BMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

BMY is expected to report earnings to rise 15.07% to $1.68 per share on October 30

Bristol-Myers Squibb Co BMY Stock Earnings Reports
Q3'25
Est.
$1.68
Q2'25
Beat
by $0.40
Q1'25
Beat
by $0.28
Q4'24
Beat
by $0.20
Q3'24
Beat
by $0.30
The last earnings report on July 31 showed earnings per share of $1.46, beating the estimate of $1.06. With 2.00M shares outstanding, the current market capitalization sits at 90.90B.
A.I.Advisor
published Dividends

BMY is expected to pay dividends on November 03, 2025

Bristol-Myers Squibb Co BMY Stock Dividends
A dividend of $0.62 per share will be paid with a record date of November 03, 2025, and an ex-dividend date of October 03, 2025. The last dividend of $0.62 was paid on August 01. Read more...
A.I. Advisor
published General Information

General Information

a manufacturer of pharmaceuticals products

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
Route 206 and Province Line Road
Phone
+1 609 252-4621
Employees
34100
Web
https://www.bms.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
BEEX25.87N/A
N/A
BeeHive ETF
DBEU46.81-0.09
-0.19%
Xtrackers MSCI Europe Hedged Equity ETF
ROE34.52-0.29
-0.84%
Astoria US Equal Weight Quality KingsETF
ESGD93.98-0.93
-0.98%
iShares ESG Aware MSCI EAFE ETF
FDRV17.65-0.38
-2.10%
Fidelity Elctrc Vhcls & Ftr Trnsptn ETF

BMY and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, BMY has been loosely correlated with PFE. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if BMY jumps, then PFE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BMY
1D Price
Change %
BMY100%
-1.06%
PFE - BMY
57%
Loosely correlated
-0.61%
MRK - BMY
50%
Loosely correlated
-1.34%
GILD - BMY
47%
Loosely correlated
+2.82%
NVS - BMY
46%
Loosely correlated
-0.53%
AMGN - BMY
45%
Loosely correlated
+0.48%
More